COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

Comparison of Monitors of Fluid Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00286338
Recruitment Status : Completed
First Posted : February 3, 2006
Last Update Posted : January 14, 2009
Information provided by:
Rigshospitalet, Denmark

Brief Summary:
The investigators want to correlate different methods to guide fluid therapy. The investigators know that guidance by esophagus doppler technique has improved outcome and want to correlate other already used techniques to esophagus doppler.

Condition or disease

Detailed Description:

Fluid therapy before and under surgery can be guided by measurement of the hearts ability to eject blood (cardiac output). By doing this it has been shown that the occurrence of nausea,vomiting and complications generally can be reduced. The function of the heart has been measured with a probe in the esophagus in in earlier studies. We want to correlate these results with other techniques by which fluid therapy also is guided in daily practice. These are: SVO2, modelflow (finapres)and NIRS.

These methods are noninvasive except SVO2 measurement which requires a central venous catheter (CVK). Therefore we have chosen a population in which CVK is standard in our institution. We thereby don´t apply any further risks than daily practice and the project is considered as a quality assessment of used standards.

Layout table for study information
Study Type : Observational
Enrollment : 12 participants
Time Perspective: Prospective
Official Title: Comparison of Monitors of Fluid Therapy
Study Start Date : February 2006
Actual Study Completion Date : April 2006

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 years or older
  • Elective urological surgery in which a central venous catheter is routinely administered
  • Informed consent

Exclusion Criteria:

  • Age 70 years or older
  • No informed consent
  • Pathology in the esophagus that contraindicates use off gastric tube and esophagus doppler
  • ASA III or above

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00286338

Layout table for location information
Dept of anesthesia 2041, ABD centre, Rigshospitalet, Blegdamsvej
Copenhagen, Denmark, DK-2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Layout table for investigator information
Study Director: Henrik Kehlet, M.D., Ph.D dept of surgical patophysiology
Layout table for additonal information Identifier: NCT00286338    
Other Study ID Numbers: des.prost-1
First Posted: February 3, 2006    Key Record Dates
Last Update Posted: January 14, 2009
Last Verified: January 2009
Keywords provided by Rigshospitalet, Denmark:
Fluid therapy
Additional relevant MeSH terms:
Layout table for MeSH terms
Pathologic Processes